These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain. Mahadik SP, Mukherjee S. Biol Psychiatry; 1995 Aug 15; 38(4):246-54. PubMed ID: 8547447 [Abstract] [Full Text] [Related]
8. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain. Garofalo L, Cuello AC. J Pharmacol Exp Ther; 1995 Feb 15; 272(2):527-45. PubMed ID: 7853166 [Abstract] [Full Text] [Related]
9. Excitatory amino acid neurotoxicity in cultured retinal neurons: involvement of N-methyl-D-aspartate (NMDA) and non-NMDA receptors and effect of ganglioside GM1. Facci L, Leon A, Skaper SD. J Neurosci Res; 1990 Oct 15; 27(2):202-10. PubMed ID: 2174980 [Abstract] [Full Text] [Related]
10. Early effects of GM1 in experimental cerebral focal ischemia in rabbits. Bo P, Marchioni E, Soragna D, Savoldi F. Boll Soc Ital Biol Sper; 1993 Nov 15; 69(11):705-10. PubMed ID: 8060600 [Abstract] [Full Text] [Related]
11. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats. Garofalo L, Cuello AC. Exp Neurol; 1994 Feb 15; 125(2):195-217. PubMed ID: 8313938 [Abstract] [Full Text] [Related]
12. Microencapsulated monosialoganglioside GM1: physical properties and in vivo effects. Maysinger D, Jalsenjak V, Stolnik S, Garofalo L, Cuello AC, Jalsenjak I. J Microencapsul; 1989 Feb 15; 6(1):35-42. PubMed ID: 2715912 [Abstract] [Full Text] [Related]
13. Reduction of ischemic brain damage by nitrous oxide and xenon. David HN, Leveille F, Chazalviel L, MacKenzie ET, Buisson A, Lemaire M, Abraini JH. J Cereb Blood Flow Metab; 2003 Oct 15; 23(10):1168-73. PubMed ID: 14526227 [Abstract] [Full Text] [Related]
14. New perspectives in the treatment of hypoxic and ischemic brain damage: effect of gangliosides. Rotondo G, Maniero G, Toffano G. Aviat Space Environ Med; 1990 Feb 15; 61(2):162-4. PubMed ID: 2178600 [Abstract] [Full Text] [Related]
15. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1. Casamenti F, Milan F, Pepeu G. Acta Neurobiol Exp (Wars); 1990 Feb 15; 50(4-5):461-73. PubMed ID: 2130662 [Abstract] [Full Text] [Related]
16. Some functional consequences of chronic GM1 ganglioside administration in brain damaged rats. Stein DG. Acta Neurobiol Exp (Wars); 1990 Feb 15; 50(4-5):405-13. PubMed ID: 2130658 [Abstract] [Full Text] [Related]
17. Gangliosides and neurotrophic factors in neurodegenerative diseases: from experimental findings to clinical perspectives. Fusco M, Vantini G, Schiavo N, Zanotti A, Zanoni R, Facci L, Skaper SD. Ann N Y Acad Sci; 1993 Sep 24; 695():314-7. PubMed ID: 8239303 [Abstract] [Full Text] [Related]
18. Pretreatment with PTD-calbindin D 28k alleviates rat brain injury induced by ischemia and reperfusion. Fan Y, Shi L, Gu Y, Zhao Y, Xie J, Qiao J, Yang GY, Wang Y, Lu CZ. J Cereb Blood Flow Metab; 2007 Apr 24; 27(4):719-28. PubMed ID: 16868556 [Abstract] [Full Text] [Related]
19. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. Gotti B, Duverger D, Bertin J, Carter C, Dupont R, Frost J, Gaudilliere B, MacKenzie ET, Rousseau J, Scatton B. J Pharmacol Exp Ther; 1988 Dec 24; 247(3):1211-21. PubMed ID: 2849668 [Abstract] [Full Text] [Related]
20. Chronic ethanol administration sensitizes hippocampal neurons to neurotoxicity of N-methyl-D-aspartic acid. Davidson M, Wilce PA, Shanley BC. Alcohol Alcohol Suppl; 1993 Dec 24; 2():365-9. PubMed ID: 7748324 [Abstract] [Full Text] [Related] Page: [Next] [New Search]